TUG1 and osteosarcoma: Then, five studies focused on TUG1 containing 294 patients were analyzed, which showed that overexpression of TUG1 was associated with unfavorable clinical outcome of osteosarcoma patients (HR = 2.41, 95%CI: 1.42–4.07, P = 0.001, Fig. 2b).